Clinical Trial Update: Long-acting Buprenorphine vs. Naltrexone Opioid Treatments in CJS-involved Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing long-acting buprenorphine with naltrexone for opioid use disorder in adults involved with the criminal justice system has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• SUBLOCADE (buprenorphine extended-release)
• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid-use Disorder | Phase 4 | Status: COMPLETED